As for the different EGFR mutation subtypes, patients with 19-Del (13.6%) suffered from a higher risk of lymph node metastasis than with wild-type (9.1%) and L858R (5.6%), although with no statistical difference (p = 0.119) [36]. This evidence concerns the gene EGFR and metastatic malignant neoplasm in the lymph nodes.